These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Use of positron emission tomography for the evaluation of epilepsy. DeCarli C; McIntosh AR; Blaxton TA Neuroimaging Clin N Am; 1995 Nov; 5(4):623-45. PubMed ID: 8564287 [TBL] [Abstract][Full Text] [Related]
3. Future advances and applications in positron emission tomography. Yoo D; Noto RB Med Health R I; 2003 May; 86(5):143-6. PubMed ID: 12803035 [No Abstract] [Full Text] [Related]
8. The contribution of positron emission tomography to the study of ischemic heart failure. Dutka DP; Camici PG Prog Cardiovasc Dis; 2001; 43(5):399-418. PubMed ID: 11251127 [TBL] [Abstract][Full Text] [Related]
9. [Positron-emission tomography in intracranial hematomas]. Rudas MS; Skvortsova TIu; Korotkov AD; Medvedev SV Zh Vopr Neirokhir Im N N Burdenko; 1997; (1):27-30. PubMed ID: 9148626 [TBL] [Abstract][Full Text] [Related]
10. Assessment: positron emission tomography. Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology; 1991 Feb; 41(2 ( Pt 1)):163-7. PubMed ID: 1992357 [No Abstract] [Full Text] [Related]
11. [11C]choline positron emission tomography/computerized tomography for early detection of prostate cancer recurrence in patients with low increasing prostate specific antigen. Giovacchini G; Picchio M; Garcia-Parra R; Mapelli P; Briganti A; Montorsi F; Gianolli L; Messa C J Urol; 2013 Jan; 189(1):105-10. PubMed ID: 23164385 [TBL] [Abstract][Full Text] [Related]
12. 11C-choline positron emission tomography/computerized tomography for tumor localization of primary prostate cancer in comparison with 12-core biopsy. Martorana G; Schiavina R; Corti B; Farsad M; Salizzoni E; Brunocilla E; Bertaccini A; Manferrari F; Castellucci P; Fanti S; Canini R; Grigioni WF; D'Errico Grigioni A J Urol; 2006 Sep; 176(3):954-60; discussion 960. PubMed ID: 16890665 [TBL] [Abstract][Full Text] [Related]
13. Contribution of 11C-choline positron emission tomography/computerized tomography to preoperative staging of advanced transitional cell carcinoma. Gofrit ON; Mishani E; Orevi M; Klein M; Freedman N; Pode D; Shapiro A; Katz R; Libson E; Chisin R J Urol; 2006 Sep; 176(3):940-4; discussion 944. PubMed ID: 16890661 [TBL] [Abstract][Full Text] [Related]
14. FDG-positron emission tomography/computerized tomography for monitoring the response of pelvic lymph node metastasis to neoadjuvant chemotherapy for bladder cancer. Mertens LS; Fioole-Bruining A; van Rhijn BW; Kerst JM; Bergman AM; Vogel WV; Vegt E; Horenblas S J Urol; 2013 May; 189(5):1687-91. PubMed ID: 23142689 [TBL] [Abstract][Full Text] [Related]
15. Comparison of 11C-choline with 18F-FDG in positron emission tomography/computerized tomography for staging urothelial carcinoma: a prospective study. Golan S; Sopov V; Baniel J; Groshar D J Urol; 2011 Aug; 186(2):436-41. PubMed ID: 21679983 [TBL] [Abstract][Full Text] [Related]
16. Operational characteristics of (11)c-choline positron emission tomography/computerized tomography for prostate cancer with biochemical recurrence after initial treatment. Mitchell CR; Lowe VJ; Rangel LJ; Hung JC; Kwon ED; Karnes RJ J Urol; 2013 Apr; 189(4):1308-13. PubMed ID: 23123372 [TBL] [Abstract][Full Text] [Related]
17. Value of acute-stage positron emission tomography in predicting neurological outcome after ischemic stroke: further assessment. Marchal G; Rioux P; Serrati C; Furlan M; Derlon JM; Viader F; Baron JC Stroke; 1995 Mar; 26(3):524-5. PubMed ID: 7886737 [No Abstract] [Full Text] [Related]